Treatment modality affects allograft-derived Schwann cell phenotype and myelinating capacity

Experimental Neurology

Volumn 212, Issue 2, 2008, Pages 324-336

  Hayashi, Ayato ^a   Moradzadeh, Arash ^a   Tong, Alice ^a   Wei, Cindy ^a   Tuffaha, Sami H ^a   Hunter, Daniel A ^a   Tung, Thomas H ^a   Parsadanian, Alexander ^a   Mackinnon, Susan E ^a   Myckatyn, Terence M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allograft; Migration; Myelin; Nestin; Phenotype; Regeneration; Schwann cell; Transgenic

Indexed keywords

CD40 LIGAND MONOCLONAL ANTIBODY; CONNEXIN 32; DEXAMETHASONE; INSULIN; MYELIN BASIC PROTEIN; NESTIN; PENICILLIN G; PROTEIN KINASE B; PROTEIN S100B; TACROLIMUS;

ACUTE GRAFT REJECTION; ALLOGRAFT; ANIMAL EXPERIMENT; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CONTROLLED STUDY; CRYOPRESERVATION; DISEASE SEVERITY; IN VIVO STUDY; MOUSE; MYELINATION; NERVE ENDING; NERVE FIBER; NERVE FIBER REGENERATION; NERVE GRAFT; NERVE RECONSTRUCTION; NERVE REGENERATION; NONHUMAN; NONMYELINATED NERVE; PERIPHERAL NERVE; PERIPHERAL NERVE INJURY; PHENOTYPE; PLASTICITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REINNERVATION; SCHWANN CELL; TRANSGENIC MOUSE;

ANIMALS; CD40 LIGAND; CONNEXINS; GENE EXPRESSION REGULATION; GRAFT REJECTION; GREEN FLUORESCENT PROTEINS; INTERMEDIATE FILAMENT PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, ELECTRON, TRANSMISSION; MOTOR ACTIVITY; MYELIN BASIC PROTEINS; NERVE REGENERATION; NERVE TISSUE PROTEINS; PHENOTYPE; S100 PROTEINS; SCHWANN CELLS; SCIATIC NEUROPATHY; SIGNAL TRANSDUCTION; TACROLIMUS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 47349096304     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2008.04.018     Document Type: Article

References (62)

1. Aguayo A.J., Charron L., and Bray G.M. Potential of Schwann cells from unmyelinated nerves to produce myelin: a quantitative ultrastructural and radiographic study. J. Neurocytol. 5 (1976) 565-573
2. Aguayo A.J., Epps J., Charron L., and Bray G.M. Multipotentiality of Schwann cells in cross-anastomosed and grafted myelinated and unmyelinated nerves: quantitative microscopy and radioautography. Brain Res. 104 (1976) 1-20
3. Ansari M.J., and Abdi R. Emerging immunomodulatory therapies targeting the co-stimulatory pathways for the prevention of transplant rejection. IDrugs 6 (2003) 964-969
4. Atanasoski S., Shumas S., Dickson C., Scherer S.S., and Suter U. Differential cyclin D1 requirements of proliferating Schwann cells during development and after injury. Mol. Cell. Neurosci. 18 (2001) 581-592
5. Atanasoski S., Scherer S.S., Sirkowski E., Leone D., Garratt A.N., Birchmeier C., and Suter U. ErbB2 signaling in Schwann cells is mostly dispensable for maintenance of myelinated peripheral nerves and proliferation of adult Schwann cells after injury. J. Neurosci. 26 (2006) 2124-2131
6. Atchabahian A., Mackinnon S.E., and Hunter D.A. Cold preservation of nerve grafts decreases expression of ICAM-1 and class II MHC antigens. J. Reconstr. Microsurg. 15 (1999) 307-311
7. Besset V., Scott R.P., and Ibanez C.F. Signaling complexes and protein-protein interactions involved in the activation of the Ras and PI3K pathways by the c-Ret receptor tyrosine kinase. J. Biol. Chem. 275 (2000) 39159-39166
8. Bonni A., Brunet A., West A.E., Datta S.R., Takasu M.A., and Greenberg M.E. Cell survival promoted by the Ras-MAPK signaling pathway by transcription dependent and -independent mechanisms [see comments]. Science 286 (1999) 1358-1362
9. Brenner M.J., Tung T.H., Mackinnon S.E., Myckatyn T.M., Hunter D.A., and Mohanakumar T. Anti-CD40 ligand monoclonal antibody induces a permissive state, but not tolerance, for murine peripheral nerve allografts. Exp. Neurol. 186 (2004) 59-69
10. Brenner M.J., Lowe III J.B., Fox I.K., Mackinnon S.E., Hunter D.A., Darcy M.D., Duncan J.R., Wood P., and Mohanakumar T. Effects of Schwann cells and donor antigen on long-nerve allograft regeneration. Microsurgery 25 (2005) 61-70
11. Brenner M.J., Mackinnon S.E., Rickman S.R., Jaramillo A., Tung T.H., Hunter D.A., and Mohanakumar T. FK506 and anti-CD40 ligand in peripheral nerve allotransplantation. Restor. Neurol. Neurosci. 23 (2005) 237-249
12. Brown C.J., Mackinnon S.E., Evans P.J., Bain J.R., Makino A.P., Hunter D.A., and Hare G.M. Self-evaluation of walking-track measurement using a Sciatic Function Index. Microsurgery 10 (1989) 226-235
13. Cen X., Nitta A., Ohya S., Zhao Y., Ozawa N., Mouri A., Ibi D., Wang L., Suzuki M., Saito K., Ito Y., Kawagoe T., Noda Y., Ito Y., Furukawa S., and Nabeshima T. An analog of a dipeptide-like structure of FK506 increases glial cell line-derived neurotrophic factor expression through cAMP response element-binding protein activated by heat shock protein 90/Akt signaling pathway. J. Neurosci. 26 (2006) 3335-3344
14. Chandross K.J., Kessler J.A., Cohen R.I., Simburger E., Spray D.C., Bieri P., and Dermietzel R. Altered connexin expression after peripheral nerve injury. Mol. Cell. Neurosci. 7 (1996) 501-518
15. Chen Z.L., Yu W.M., and Strickland S. Peripheral regeneration. Annu. Rev. Neurosci. 30 (2007) 209-233
16. Feng G., Mellor R.H., Bernstein M., Keller-Peck C., Nguyen Q.T., Wallace M., Nerbonne J.M., Lichtman J.W., and Sanes J.R. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neuron 28 (2000) 41-51
17. Finn J.T., Weil M., Archer F., Siman R., Srinivasan A., and Raff M.C. Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J. Neurosci. 20 (2000) 1333-1341
18. Fox I.K., Jaramillo A., Hunter D.A., Rickman S.R., Mohanakumar T., and Mackinnon S.E. Prolonged cold-preservation of nerve allografts. Muscle Nerve 31 (2005) 59-69
19. Gold B.G. FK506 and the role of the immunophilin FKBP-52 in nerve regeneration. Drug Metab. Rev. 31 (1999) 649-663
20. Gold B.G., Storm-Dickerson T., and Austin D.R. The immunosuppressant FK506 increases functional recovery and nerve regeneration following peripheral nerve injury. Restor. Neurol. Neurosci. 6 (1994) 287-296
21. Gottlieb R.A., and Kitsis R.N. Seeing death in the living. Nat. Med. 7 (2001) 1277-1278
22. Grand A.G., Myckatyn T.M., Mackinnon S.E., and Hunter D.A. Axonal regeneration after cold preservation of nerve allografts and immunosuppression with tacrolimus in mice. J. Neurosurg. 96 (2002) 924-932
23. Gundersen H.J., Bagger P., Bendtsen T.F., Evans S.M., Korbo L., Marcussen N., Moller A., Nielsen K., Nyengaard J.R., Pakkenberg B., et al. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 96 (1988) 857-881
24. Hare G.M., Evans P.J., Mackinnon S.E., Best T.J., Bain J.R., Szalai J.P., and Hunter D.A. Walking track analysis: a long-term assessment of peripheral nerve recovery. Plast. Reconstr. Surg. 89 (1992) 251-258
25. Harrisingh M.C., Perez-Nadales E., Parkinson D.B., Malcolm D.S., Mudge A.W., and Lloyd A.C. The Ras/Raf/ERK signalling pathway drives Schwann cell dedifferentiation. EMBO J. 23 (2004) 3061-3071
26. Hayashi A., Koob J.W., Liu D.Z., Tong A.Y., Hunter D.A., Parsadanian A., Mackinnon S.E., and Myckatyn T.M. A double-transgenic mouse used to track migrating Schwann cells and regenerating axons following engraftment of injured nerves. Exp. Neurol. 207 (2007) 128-138
27. Hayworth C.R., Moody S.E., Chodosh L.A., Krieg P., Rimer M., and Thompson W.J. Induction of neuregulin signaling in mouse Schwann cells in vivo mimics responses to denervation. J. Neurosci. 26 (2006) 6873-6884
28. Hockfield S., and McKay R.D. Identification of major cell classes in the developing mammalian nervous system. J. Neurosci. 5 (1985) 3310-3328
29. Hunter D.A., Moradzadeh A., Whitlock E.L., Brenner M.J., Myckatyn T.M., Wei C.H., Tung T.H., and Mackinnon S.E. Binary imaging analysis for comprehensive quantitative histomorphometry of peripheral nerve. J. Neurosci. Methods 166 (2007) 116-124
30. Inserra M.M., Bloch D.A., and Terris D.J. Functional indices for sciatic, peroneal, and posterior tibial nerve lesions in the mouse. Microsurgery 18 (1998) 119-124
31. Jessen K.R., and Mirsky R. The origin and development of glial cells in peripheral nerves. Nat. Rev., Neurosci. 6 (2005) 671-682
32. Jost S.C., Doolabh V.B., Mackinnon S.E., Lee M., and Hunter D. Acceleration of peripheral nerve regeneration following FK506 administration. Restor. Neurol. Neurosci. 17 (2000) 39-44
33. Kang H., Tian L., Son Y.J., Zuo Y., Procaccino D., Love F., Hayworth C., Trachtenberg J., Mikesh M., Sutton L., Ponomareva O., Mignone J., Enikolopov G., Rimer M., and Thompson W. Regulation of the intermediate filament protein nestin at rodent neuromuscular junctions by innervation and activity. J. Neurosci. 27 (2007) 5948-5957
34. Kimura A., Ajiki T., Takeuchi K., Hakamata Y., Murakami T., Hoshino Y., and Kobayashi E. Transmigration of donor cells involved in the sciatic nerve graft. Transplant. Proc. 37 (2005) 205-207
35. Kirk A.D., Harlan D.M., Armstrong N.N., Davis T.A., Dong Y., Gray G.S., Hong X., Thomas D., Fechner Jr. J.H., and Knechtle S.J. CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 8789-8794
36. Kirk A.D., Burkly L.C., Batty D.S., Baumgartner R.E., Berning J.D., Buchanan K., Fechner Jr. J.H., Germond R.L., Kampen R.L., Patterson N.B., Swanson S.J., Tadaki D.K., TenHoor C.N., White L., Knechtle S.J., and Harlan D.M. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat. Med. 5 (1999) 686-692
37. Kist-van Holthe J.E., Gasser M., Womer K., Najafian N., Dong V., Samsonov D.V., Geehan C.S., Chandraker A., Sayegh M.H., and Waaga A.M. Regulatory functions of alloreactive Th2 clones in human renal transplant recipients. Kidney Int. 62 (2002) 627-631
38. Larsen C.P., Elwood E.T., Alexander D.Z., Ritchie S.C., Hendrix R., Tucker-Burden C., Cho H.R., Aruffo A., Hollenbaugh D., Linsley P.S., Winn K.J., and Pearson T.C. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381 (1996) 434-438
39. Lyons D.A., Pogoda H.M., Voas M.G., Woods I.G., Diamond B., Nix R., Arana N., Jacobs J., and Talbot W.S. erbb3 and erbb2 are essential for Schwann cell migration and myelination in zebrafish. Curr. Biol. 15 (2005) 513-524
40. Mackinnon S.E., and Hudson A.R. Clinical application of peripheral nerve transplantation. Plast. Reconstr. Surg. 90 (1992) 695-699
41. Mackinnon S.E., Doolabh V.B., Novak C.B., and Trulock E.P. Clinical outcome following nerve allograft transplantation. Plast. Reconstr. Surg. 107 (2001) 1419-1429
42. Magill C.K., Tong A., Kawamura D., Hayashi A., Hunter D.A., Parsadanian A., Mackinnon S.E., and Myckatyn T.M. Reinnervation of the tibialis anterior following sciatic nerve crush injury: a confocal microscopic study in transgenic mice. Exp. Neurol. 207 (2007) 64-74
43. Magott-Procelewska M. Costimulatory pathways as a basic mechanisms of activating a tolerance signal in T cells. Ann. Transplant. 9 (2004) 13-18
44. Mambetisaeva E.T., Gire V., and Evans W.H. Multiple connexin expression in peripheral nerve, Schwann cells, and Schwannoma cells. J. Neurosci. Res. 57 (1999) 166-175
45. Midha R., Mackinnon S.E., and Becker L.E. The fate of Schwann cells in peripheral nerve allografts. J. Neuropathol. Exp. Neurol. 53 (1994) 316-322
46. Mignone J.L., Kukekov V., Chiang A.S., Steindler D., and Enikolopov G. Neural stem and progenitor cells in nestin-GFP transgenic mice. J. Comp. Neurol. 469 (2004) 311-324
47. Mograbi B., Bocciardi R., Bourget I., Busca R., Rochet N., Farahi-Far D., Juhel T., and Rossi B. Glial cell line-derived neurotrophic factor-stimulated phosphatidylinositol 3-kinase and Akt activities exert opposing effects on the ERK pathway: importance for the rescue of neuroectodermic cells. J. Biol. Chem. 276 (2001) 45307-45319
48. Myckatyn T.M., Ellis R.A., Grand A.G., Sen S.K., Lowe III J.B., Hunter D.A., and Mackinnon S.E. The effects of rapamycin in murine peripheral nerve isografts and allografts. Plast. Reconstr. Surg. 109 (2002) 2405-2417
49. Myckatyn T.M., Hunter D.A., and Mackinnon S.E. The effects of cold preservation and subimmunosuppressive doses of FK506 on axonal regeneration in murine peripheral nerve isografts. Can. J. Plast. Surg. 11 (2003) 15-22
50. Myckatyn T.M., and MacKinnon S.E. A review of research endeavors to optimize peripheral nerve reconstruction. Neurol. Res. 26 (2004) 124-138
51. Ogata T., Iijima S., Hoshikawa S., Miura T., Yamamoto S., Oda H., Nakamura K., and Tanaka S. Opposing extracellular signal-regulated kinase and Akt pathways control Schwann cell myelination. J. Neurosci. 24 (2004) 6724-6732
52. Pan Y.A., Misgeld T., Lichtman J.W., and Sanes J.R. Effects of neurotoxic and neuroprotective agents on peripheral nerve regeneration assayed by time-lapse imaging in vivo. J. Neurosci. 23 (2003) 11479-11488
53. Perez V.J., and Moore B.W. Wallerian degeneration in rabbit tibial nerve: changes in amounts of the S-100 protein. J. Neurochem. 15 (1968) 971-977
54. Scherer S.S., Deschenes S.M., Xu Y.T., Grinspan J.B., Fischbeck K.H., and Paul D.L. Connexin-32 is a myelin-related protein in the PNS and CNS. J. Neurosci. 15 (1995) 8281-8294
55. Shen Z.L., Lassner F., Bader A., Becker M., Walter G.F., and Berger A. Cellular activity of resident macrophages during Wallerian degeneration. Microsurgery 20 (2000) 255-261
56. Steiner J.P., Connolly M.A., Valentine H.L., Hamilton G.S., Dawson T.M., Hester L., and Snyder S.H. Neurotrophic actions of nonimmunosuppressive analogues of immunsuppressive drugs FK506, rapamycin, and cyclosporin A. Nat. Med. 3 (1997) 421-428
57. Taveggia C., Zanazzi G., Petrylak A., Yano H., Rosenbluth J., Einheber S., Xu X., Esper R.M., Loeb J.A., Shrager P., Chao M.V., Falls D.L., Role L., and Salzer J.L. Neuregulin-1 type III determines the ensheathment fate of axons. Neuron 47 (2005) 681-694
58. Veit C., Genze F., Menke A., Hoeffert S., Gress T.M., Gierschik P., and Giehl K. Activation of phosphatidylinositol 3-kinase and extracellular signal-regulated kinase is required for glial cell line-derived neurotrophic factor-induced migration and invasion of pancreatic carcinoma cells. Cancer Res. 64 (2004) 5291-5300
59. Xia Z., Dickens M., Raingeaud J., Davis R.J., and Greenberg M.E. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270 (1995) 1326-1331
60. Zalewski A.A., and Gulati A.K. Survival of nerve and Schwann cells in allografts after cyclosporin A treatment. Exp. Neurol. 70 (1980) 219-225
61. Zawadzka M., and Kaminska B. Immunosuppressant FK506 affects multiple signaling pathways and modulates gene expression in astrocytes. Mol. Cell. Neurosci. 22 (2003) 202-209
62. Zuo Y., Lubischer J.L., Kang H., Tian L., Mikesh M., Marks A., Scofield V.L., Maika S., Newman C., Krieg P., and Thompson W.J. Fluorescent proteins expressed in mouse transgenic lines mark subsets of glia, neurons, macrophages, and dendritic cells for vital examination. J. Neurosci. 24 (2004) 10999-11009